{"filing":{"accession_number":"0001213900-26-092944","cik":"0001560293","ticker":"TNONW","company_name":"Tenon Medical, Inc.","form":"8-K","filing_date":"2026-08-24","report_date":"2026-08-24","primary_document":"ea0303191-8k_tenon.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1560293/000121390026092944/ea0303191-8k_tenon.htm"},"events":[{"id":29125,"run_id":26651,"accession_number":"0001213900-26-092944","anchor_item_number":"8.01","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.92,"summary":"Tenon Medical disclosed that it has regained compliance with Nasdaq's minimum bid price requirement (Listing Rule 5550(a)(2)) following a reverse stock split. The company had previously received a non-compliance notice on February 25, 2026, and has now resolved this delisting risk through the 1-for-35 reverse split effective August 10, 2026. This is a material event because the minimum bid price requirement is a continued listing standard, and failure to maintain compliance directly threatens the company's continued listing on Nasdaq.","company_name":"Tenon Medical, Inc.","ticker":"TNONW","filing_date":"2026-08-24","form":"8-K","submitted_at":null,"items":[{"id":31295,"accession_number":"0001213900-26-092944","item_number":"8.01","item_title":"Other Events.","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.92,"reasoning":"Tenon Medical disclosed that it has regained compliance with Nasdaq's minimum bid price requirement (Listing Rule 5550(a)(2)) following a reverse stock split. The company had previously received a non-compliance notice on February 25, 2026, and has now resolved this delisting risk through the 1-for-35 reverse split effective August 10, 2026. This is a material event because the minimum bid price requirement is a continued listing standard, and failure to maintain compliance directly threatens the company's continued listing on Nasdaq.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-24T17:24:40.450921+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":31295,"accession_number":"0001213900-26-092944","item_number":"8.01","item_title":"Other Events.","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.92,"reasoning":"Tenon Medical disclosed that it has regained compliance with Nasdaq's minimum bid price requirement (Listing Rule 5550(a)(2)) following a reverse stock split. The company had previously received a non-compliance notice on February 25, 2026, and has now resolved this delisting risk through the 1-for-35 reverse split effective August 10, 2026. This is a material event because the minimum bid price requirement is a continued listing standard, and failure to maintain compliance directly threatens the company's continued listing on Nasdaq.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-24T17:24:40.450921+00:00","company_name":"Tenon Medical, Inc.","ticker":"TNONW","filing_date":"2026-08-24"}]}